middle.news
Why Is Atomo Diagnostics’ Stock Surging Amid Lumos FDA News?
8:04pm on Wednesday 25th of March, 2026 AEDT
•
Healthcare
Read Story
Why Is Atomo Diagnostics’ Stock Surging Amid Lumos FDA News?
8:04pm on Wednesday 25th of March, 2026 AEDT
Key Points
Atomo denies undisclosed price-sensitive information amid recent trading surge
Acknowledges Lumos Diagnostics' FDA response on FebriDx® CLIA waiver application
FebriDx® test uses Atomo's patented Pascal cassette technology
Atomo unable to assess impact of FDA response on its business currently
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
ATOMO DIAGNOSTICS (ASX:AT1)
OPEN ARTICLE